Relationship of EGFR DNA methylation with the severity of non-small cell lung cancer

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 11915-11923

  Li, J ^a   Jia, X F ^a   Liu, J ^b   Liu, J J ^a   Zhao, H B ^a  

^a First Peoples Hospital of Jining   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

DNA methylation; Epidermal growth factor receptor; Nom small cell lung cancer

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; CPG ISLAND; DISEASE SEVERITY; DNA METHYLATION; EGFR GENE; FEMALE; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PROMOTER REGION; PYROSEQUENCING; SEX DIFFERENCE; SMOKING; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER;

EID: 84943591461     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.October.5.5     Document Type: Article

References (20)

1. Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, et al. (2003). Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J. Clin. Oncol. 21: 3798-3807.
2. Hynes NE and Lane HA (2005). ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5: 341-354.
3. Jemal A, Siegel R, Xu J and Ward E (2010). Cancer statistics, 2010. CA Cancer J. Clin. 60: 277-300.
4. Kashiwababra K, Oyama T, Sano T, Fukuda T, et al. (1998). Correlation between methylation status of the p16/CDK2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers. Ins. J. Cancer 79: 215-220.
5. Li E, Bestor TH and Jaenisch R (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926.
6. Loeb DM, Evron E, Patel CB, Sharma PM, et al. (2001). Wilms’ tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res. 61: 921-925.
7. Mendelsohn J and Baselga J (2003). Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J. Clin. Oncol. 21: 2787-2799.
8. Métivier R, Gallais R, Tiffoche C, Le Péron C, et al. (2008). Cyclical DNA methylation of a transcriptionally active promoter. Nature 452: 45-50.
9. Montero AJ, Diaz-Montero CM, Mao L, Youssef AM, et al. (2006). Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer. Cancer Biol. Ther. 5: 1494-1501.
10. Oh MJ, Choi JH, Kim IH, Lee YH, et al. (2000). Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma. Clin. Cancer Res. 6: 4760-4763.
11. Ohsaki Y, Tanno S, Fujita Y, Toyoshima E, et al. (2000). Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol. Rep. 7: 603-607.
12. Palii SS and Robertson KD (2007). Epigenetic control of tumor suppression. Crit. Rev. Eukaryot. Gene Expr. 17: 295-316.
13. Parra HS, Cavina R, Latteri F, Zucali PA, et al. (2004). Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib (‘Iressa’, ZD1839) in non-small-cell lung cancer. Br. J. Cancer 91: 208-212.
14. Piyathilake CJ, Frost AR, Manne U, Weiss H, et al. (2002). Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin. Cancer Res. 8: 734-744.
15. Raben D, Helfrich BA, Chan D, Johnson G, et al. (2002). ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin. Oncol. 29: 37-46.
16. Reungwetwattana T, Weroha SJ and Molina JR (2012). Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC). Clin. Lung Cancer 13: 252-266.
17. Scartozzi M, Bearzi I, Mandolesi A, Giampieri R, et al. (2011). Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients. Br. J. Cancer 104: 1786-1790.
18. Sharma SV, Bell DW, Settleman J and Haber DA (2007). Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7: 169-181.
19. Tost J and Gut IG (2007). Analysis of gene-specific DNA methylation patterns by pyrosequencing technology. Methods Mol. Biol. 373: 89-102.
20. Tost J, El abdalaoui H and Gut IG (2006). Serial pyrosequencing for quantitative DNA methylation analysis. Biotechniques 40: 721-726.